Ashton Thomas Private Wealth’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.83M Buy
11,663
+252
+2% +$37.8K 0.04% 397
2026
Q1
$1.74M Buy
11,411
+961
+9% +$147K 0.04% 397
2025
Q4
$1.44M Buy
10,450
+630
+6% +$82.5K 0.04% 395
2025
Q3
$1.26M Buy
9,820
+2,255
+30% +$275K 0.03% 413
2025
Q2
$915K Buy
7,565
+4,588
+154% +$517K 0.03% 431
2025
Q1
$344K Sell
2,977
-201
-6% -$21.4K 0.01% 631
2024
Q4
$309K Buy
3,178
+211
+7% +$22.5K 0.01% 624
2024
Q3
$341K Buy
2,967
+354
+14% +$40.2K 0.02% 491
2024
Q2
$278K Sell
2,613
-189
-7% -$19K 0.02% 504
2024
Q1
$271K Sell
2,802
-160
-5% -$16.4K 0.02% 510
2023
Q4
$299K Hold
2,962
0.02% 497
2023
Q3
$302K Buy
2,962
+386
+15% +$39.2K 0.02% 473
2023
Q2
$260K Buy
2,576
+184
+8% +$18.4K 0.02% 508
2023
Q1
$220K Buy
+2,392
New +$209K 0.02% 464
2022
Q3
Sell
-2,372
Closed -$201K 477
2022
Q2
$201K Buy
+2,372
New +$208K 0.02% 436
2021
Q3
Sell
-8,195
Closed -$748K 377
2021
Q2
$748K Buy
+8,195
New +$730K 0.11% 197
2019
Q2
Sell
-2,682
Closed -$231K 197
2019
Q1
$231K Buy
+2,682
New +$215K 0.1% 168

Other funds holding NVS

Ashton Thomas Private Wealth's NVS Position: Q2 2026 in Review

Ashton Thomas Private Wealth increased its Novartis (NVS) stake by 2.2% in Q2 2026, buying an estimated $37.8K and bringing the position to 11,663 shares worth $1.83M. The position accounts for 0.04% of the portfolio, ranked #397.

Ashton Thomas Private Wealth first reported a position in NVS in Q1 2019 and has held it in 17 quarters since. 1,612 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Ashton Thomas Private Wealth held 11,663 shares of Novartis worth $1.83M as of Q2 2026.
  • Ashton Thomas Private Wealth bought 252 Novartis shares in Q2 2026, an estimated $37.8K.
  • Novartis made up 0.04% of Ashton Thomas Private Wealth's portfolio in Q2 2026, its #397 holding.
  • Ashton Thomas Private Wealth first reported a position in Novartis in Q1 2019 and has held it in 17 quarters since.
  • 1,612 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.